Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38


Cerebral Expression of Glial Fibrillary Acidic Protein, Ubiquitin Carboxy-Terminal Hydrolase-L1, and Matrix Metalloproteinase 9 After Traumatic Brain Injury and Secondary Brain Insults in Rats.

Mrozek S, Delamarre L, Capilla F, Al-Saati T, Fourcade O, Constantin JM, Geeraerts T.

Biomark Insights. 2019 Jun 4;14:1177271919851515. doi: 10.1177/1177271919851515. eCollection 2019.


Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models.

Xiong H, Mittman S, Rodriguez R, Pacheco-Sanchez P, Moskalenko M, Yang Y, Elstrott J, Ritter AT, Müller S, Nickles D, Arenzana TL, Capietto AH, Delamarre L, Modrusan Z, Rutz S, Mellman I, Cubas R.

Cancer Immunol Res. 2019 Jun;7(6):963-976. doi: 10.1158/2326-6066.CIR-18-0750. Epub 2019 May 7.


How Much Do Benzodiazepines Matter for Electroconvulsive Therapy in Patients With Major Depression?

Delamarre L, Galvao F, Gohier B, Poulet E, Brunelin J.

J ECT. 2019 Sep;35(3):184-188. doi: 10.1097/YCT.0000000000000574.


The immunotherapy prize!

Delamarre L.

Sci Adv. 2018 May 2;4(5):eaat7955. doi: 10.1126/sciadv.aat7955. eCollection 2018 May. No abstract available.


Characterizing neoantigens for personalized cancer immunotherapy.

Capietto AH, Jhunjhunwala S, Delamarre L.

Curr Opin Immunol. 2017 Jun;46:58-65. doi: 10.1016/j.coi.2017.04.007. Epub 2017 May 4. Review.


Building proteomic tool boxes to monitor MHC class I and class II peptides.

Schumacher FR, Delamarre L, Jhunjhunwala S, Modrusan Z, Phung QT, Elias JE, Lill JR.

Proteomics. 2017 Jan;17(1-2). doi: 10.1002/pmic.201600061. Review.


IMMUNOTHERAPY. Outsourcing the immune response to cancer.

Yadav M, Delamarre L.

Science. 2016 Jun 10;352(6291):1275-6. doi: 10.1126/science.aag1547. No abstract available.


Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells.

Katakam AK, Brightbill H, Franci C, Kung C, Nunez V, Jones C 3rd, Peng I, Jeet S, Wu LC, Mellman I, Delamarre L, Austin CD.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14664-9. doi: 10.1073/pnas.1520627112. Epub 2015 Nov 11.


Cancer immunotherapy. Neo approaches to cancer vaccines.

Delamarre L, Mellman I, Yadav M.

Science. 2015 May 15;348(6236):760-1. doi: 10.1126/science.aab3465. No abstract available.


Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

Yadav M, Jhunjhunwala S, Phung QT, Lupardus P, Tanguay J, Bumbaca S, Franci C, Cheung TK, Fritsche J, Weinschenk T, Modrusan Z, Mellman I, Lill JR, Delamarre L.

Nature. 2014 Nov 27;515(7528):572-6. doi: 10.1038/nature14001.


Dendritic cell-targeted vaccines.

Cohn L, Delamarre L.

Front Immunol. 2014 May 30;5:255. doi: 10.3389/fimmu.2014.00255. eCollection 2014. Review.


Endosomes are specialized platforms for bacterial sensing and NOD2 signalling.

Nakamura N, Lill JR, Phung Q, Jiang Z, Bakalarski C, de Mazière A, Klumperman J, Schlatter M, Delamarre L, Mellman I.

Nature. 2014 May 8;509(7499):240-4. doi: 10.1038/nature13133. Epub 2014 Mar 30.


Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation.

Vander Lugt B, Khan AA, Hackney JA, Agrawal S, Lesch J, Zhou M, Lee WP, Park S, Xu M, DeVoss J, Spooner CJ, Chalouni C, Delamarre L, Mellman I, Singh H.

Nat Immunol. 2014 Feb;15(2):161-7. doi: 10.1038/ni.2795. Epub 2013 Dec 22.


Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation.

Cohn L, Chatterjee B, Esselborn F, Smed-Sörensen A, Nakamura N, Chalouni C, Lee BC, Vandlen R, Keler T, Lauer P, Brockstedt D, Mellman I, Delamarre L.

J Exp Med. 2013 May 6;210(5):1049-63. doi: 10.1084/jem.20121251. Epub 2013 Apr 8.


Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells.

Chatterjee B, Smed-Sörensen A, Cohn L, Chalouni C, Vandlen R, Lee BC, Widger J, Keler T, Delamarre L, Mellman I.

Blood. 2012 Sep 6;120(10):2011-20. doi: 10.1182/blood-2012-01-402370. Epub 2012 Jul 12.


Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells.

Smed-Sörensen A, Chalouni C, Chatterjee B, Cohn L, Blattmann P, Nakamura N, Delamarre L, Mellman I.

PLoS Pathog. 2012;8(3):e1002572. doi: 10.1371/journal.ppat.1002572. Epub 2012 Mar 8.


Harnessing dendritic cells for immunotherapy.

Delamarre L, Mellman I.

Semin Immunol. 2011 Feb;23(1):2-11. doi: 10.1016/j.smim.2011.02.001. Epub 2011 Mar 5. Review.


Mature dendritic cells use endocytic receptors to capture and present antigens.

Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, Carano RA, Mellman I, Delamarre L.

Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4287-92. doi: 10.1073/pnas.0910609107. Epub 2010 Feb 8.


Differential role of the Ca(2+) sensor synaptotagmin VII in macrophages and dendritic cells.

Becker SM, Delamarre L, Mellman I, Andrews NW.

Immunobiology. 2009;214(7):495-505. doi: 10.1016/j.imbio.2008.11.006. Epub 2009 Jan 20.


Spinophilin participates in information transfer at immunological synapses.

Bloom O, Unternaehrer JJ, Jiang A, Shin JS, Delamarre L, Allen P, Mellman I.

J Cell Biol. 2008 Apr 21;181(2):203-11. doi: 10.1083/jcb.200711149. Epub 2008 Apr 14.


Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.

Shin JS, Ebersold M, Pypaert M, Delamarre L, Hartley A, Mellman I.

Nature. 2006 Nov 2;444(7115):115-8. Epub 2006 Oct 8.


Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis.

Delamarre L, Couture R, Mellman I, Trombetta ES.

J Exp Med. 2006 Sep 4;203(9):2049-55. Epub 2006 Aug 14.


Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.

Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES.

Science. 2005 Mar 11;307(5715):1630-4.


Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.

Blot V, Delamarre L, Perugi F, Pham D, Bénichou S, Benarous R, Hanada T, Chishti AH, Dokhélar MC, Pique C.

J Cell Sci. 2004 Aug 1;117(Pt 17):3983-93.


HTLV-1 structural proteins.

Le Blanc I, Grange MP, Delamarre L, Rosenberg AR, Blot V, Pique C, Dokhélar MC.

Virus Res. 2001 Oct 30;78(1-2):5-16. Review.


Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface.

Grange MP, Blot V, Delamarre L, Bouchaert I, Rocca A, Dautry-Varsat A, Dokhélar MC.

J Virol. 2000 Dec;74(24):11734-43.


Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.

Pique C, Lagaudrière-Gesbert C, Delamarre L, Rosenberg AR, Conjeaud H, Dokhélar MC.

Virology. 2000 Oct 25;276(2):455-65.


The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission.

Delamarre L, Pique C, Rosenberg AR, Blot V, Grange MP, Le Blanc I, Dokhélar MC.

J Virol. 1999 Nov;73(11):9659-63.


Early assembly step of a retroviral envelope glycoprotein: analysis using a dominant negative assay.

Rosenberg AR, Delamarre L, Pique C, Le Blanc I, Griffith G, Dokhélar MC.

J Cell Biol. 1999 Apr 5;145(1):57-68.


The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.

Rosenberg AR, Delamarre L, Pique C, Pham D, Dokhélar MC.

J Virol. 1997 Oct;71(10):7180-6.


Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein.

Lodge R, Delamarre L, Lalonde JP, Alvarado J, Sanders DA, Dokhélar MC, Cohen EA, Lemay G.

J Virol. 1997 Jul;71(7):5696-702.


The HTLV-I envelope glycoproteins: structure and functions.

Delamarre L, Rosenberg AR, Pique C, Pham D, Callebaut I, Dokhélar MC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S85-91. Review.


Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Delamarre L, Pique C, Pham D, Tursz T, Dokhélar MC.

J Virol. 1994 Jun;68(6):3544-9.


The open reading frame I (ORF I)/ORF II part of the human T-cell leukemia virus type I X region is dispensable for p40tax, p27rex, or envelope expression.

Roithmann S, Pique C, Le Cesne A, Delamarre L, Pham D, Tursz T, Dokhélar MC.

J Virol. 1994 May;68(5):3448-51.

Supplemental Content

Loading ...
Support Center